Grégory Behar
Fortune : 968 189 $ au 31/05/2026
Fortune : 968 189 $ au 31/05/2026
Grégory Behar currently works at Recipharm AB, as Chief Executive Officer from 2024, Nestle Health Science SA (Private Equity), as President & CEO from 2014, Recipharm Karlskoga AB, as Chief Executive Officer from 2024, Recipharm Pharmaceutical Development AB, as Chief Executive Officer from 2024, Nutrition Science Partners Ltd., as Chairman, Sonova Holding AG, as Independent Non-Executive Director from 2021, Prometheus Laboratories, Inc., as Director, Amazentis SA, as Director, and Nestlé Health Science (Deutschland) GmbH, as Member-Supervisory Board.
Mr. Behar also formerly worked at Boehringer Ingelheim Pharmaceuticals, Inc., as President & Chief Executive Officer from 2011 to 2014, Nestle Health Science SA, as Chief Executive Officer, Nestlé Health Science France SAS, as Chief Executive Officer, Cerecin, Inc., as Director, Seres Therapeutics, Inc., as Independent Director from 2014 to 2023, Axcella Health, Inc., as Independent Director from 2016 to 2022, Aimmune Therapeutics, Inc., as Independent Director from 2016 to 2020, Prometheus Biosciences, Inc., as Director, Boehringer Ingelheim GmbH, as Vice President-NECAR Region from 2010 to 2011, and Nestlé SA, as Manager in 2000.
Mr. Behar received his graduate degree from École Polytechnique Fédérale de Lausanne, undergraduate degree from the University of California, Los Angeles, and Masters Business Admin degree from INSEAD.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SONOVA HOLDING AG 0,01 % | 31/03/2026 | 3 644 ( 0,01 % ) | 968 189 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SONOVA HOLDING AG | Directeur/Membre du Conseil | 15/06/2021 |
| RECIPHARM AB (PUBL) | Directeur Général | 01/01/2024 |
Nutrition Science Partners Ltd.
Nutrition Science Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Président | - |
Recipharm Pharmaceutical Development AB
Recipharm Pharmaceutical Development AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/01/2024 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development of life sciences | Directeur/Membre du Conseil | - |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Directeur/Membre du Conseil | - |
Nestlé Health Science (Deutschland) GmbH
Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Develops nutritional therapies | Directeur/Membre du Conseil | - |
Nestle Health Science SA (Private Equity)
Nestle Health Science SA (Private Equity) Investment ManagersFinance Nestle Health Science SA (Private Equity) invests in later stage companies globally. The fund targets companies operating in the field of nutritional therapies. It acquires minority positions. The fund considers co-investments. | Directeur Général | 01/07/2014 |
Recipharm Karlskoga AB
Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Manufactures and develops oral solid & liquid dosage form of pharmaceutical products | Directeur Général | 01/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 22 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Nestlé SA
Nestlé SA Food: Major DiversifiedConsumer Non-Durables Produces, supplies and markets chocolates, frozen food, ice creams, dairy products and pet food | Consumer Non-Durables |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
Sonova Holding AG
Sonova Holding AG Medical SpecialtiesHealth Technology Develops and markets hearing care solutions | Health Technology |
École Polytechnique Fédérale de Lausanne
École Polytechnique Fédérale de Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recipharm AB
Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development of life sciences | Commercial Services |
Recipharm Karlskoga AB
Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Manufactures and develops oral solid & liquid dosage form of pharmaceutical products | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
Nestle Health Science SA (Private Equity)
Nestle Health Science SA (Private Equity) Investment ManagersFinance Nestle Health Science SA (Private Equity) invests in later stage companies globally. The fund targets companies operating in the field of nutritional therapies. It acquires minority positions. The fund considers co-investments. | Finance |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Recipharm Pharmaceutical Development AB
Recipharm Pharmaceutical Development AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Nutrition Science Partners Ltd.
Nutrition Science Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
Nestlé Health Science (Deutschland) GmbH
Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Develops nutritional therapies | Health Technology |
Nestlé Health Science France SAS
Nestlé Health Science France SAS Pharmaceuticals: OtherHealth Technology Manufactures and distributes nutritional health care products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national